These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis. Liu F; Goh GB; Tiniakos D; Wee A; Leow WQ; Zhao JM; Rao HY; Wang XX; Wang Q; Wan WK; Lim KH; Romero-Gomez M; Petta S; Bugianesi E; Tan CK; Harrison SA; Anstee QM; Chang PJ; Wei L Hepatology; 2020 Jun; 71(6):1953-1966. PubMed ID: 31600834 [TBL] [Abstract][Full Text] [Related]
10. Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score. Pai RK; Jairath V; Hogan M; Zou G; Adeyi OA; Anstee QM; Aqel BA; Behling C; Carey EJ; Clouston AD; Corey K; Feagan BG; Kleiner DE; Ma C; McFarlane SC; Noureddin M; Ratziu V; Valasek MA; Younossi ZM; Harrison SA; Loomba R Hepatology; 2022 Oct; 76(4):1150-1163. PubMed ID: 35332569 [TBL] [Abstract][Full Text] [Related]
11. Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis. Kim HP; Idowu MO; Mospan AR; Allmon AG; Roden M; Newsome P; Lok AS; Thuluvath PJ; Taunk J; Fried MW; Sanyal AJ; Barritt AS; Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1472-1480. PubMed ID: 34694013 [TBL] [Abstract][Full Text] [Related]
12. A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy. Lee K; Jung ES; Yu E; Kang YK; Cho MY; Kim JM; Moon WS; Jeong JS; Park CK; Park JB; Kang DY; Sohn JH; Jin SY J Pathol Transl Med; 2020 May; 54(3):228-236. PubMed ID: 32460476 [TBL] [Abstract][Full Text] [Related]
13. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Kleiner DE; Brunt EM; Van Natta M; Behling C; Contos MJ; Cummings OW; Ferrell LD; Liu YC; Torbenson MS; Unalp-Arida A; Yeh M; McCullough AJ; Sanyal AJ; Hepatology; 2005 Jun; 41(6):1313-21. PubMed ID: 15915461 [TBL] [Abstract][Full Text] [Related]
14. Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies. Heinemann F; Gross P; Zeveleva S; Qian HS; Hill J; Höfer A; Jonigk D; Diehl AM; Abdelmalek M; Lenter MC; Pullen SS; Guarnieri P; Stierstorfer B Sci Rep; 2022 Nov; 12(1):19236. PubMed ID: 36357500 [TBL] [Abstract][Full Text] [Related]
15. Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study. Bastati N; Perkonigg M; Sobotka D; Poetter-Lang S; Fragner R; Beer A; Messner A; Watzenboeck M; Pochepnia S; Kittinger J; Herold A; Kristic A; Hodge JC; Traussnig S; Trauner M; Ba-Ssalamah A; Langs G Eur Radiol; 2023 Nov; 33(11):7729-7743. PubMed ID: 37358613 [TBL] [Abstract][Full Text] [Related]
16. AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trials. Iyer JS; Pokkalla H; Biddle-Snead C; Carrasco-Zevallos O; Lin M; Shanis Z; Le Q; Juyal D; Pouryahya M; Pedawi A; Hoffman S; Elliott H; Leidal K; Myers RP; Chung C; Billin AN; Watkins TR; Resnick M; Wack K; Glickman J; Burt AD; Loomba R; Sanyal AJ; Montalto MC; Beck AH; Taylor-Weiner A; Wapinski I medRxiv; 2023 Apr; ():. PubMed ID: 37162870 [TBL] [Abstract][Full Text] [Related]